Lexicon Pharmaceuticals (LXRX) Non Operating Investment Income: 2009-2011
Historic Non Operating Investment Income for Lexicon Pharmaceuticals (LXRX) over the last 1 years, with Mar 2011 value amounting to $35,000.
- Lexicon Pharmaceuticals' Non Operating Investment Income fell 60.23% to $35,000 in Q1 2011 from the same period last year, while for Mar 2011 it was -$2.9 million, marking a year-over-year decrease of 26.60%. This contributed to the annual value of $141,000 for FY2010, which is 104.02% up from last year.
- As of Q1 2011, Lexicon Pharmaceuticals' Non Operating Investment Income stood at $35,000, which was down 33.96% from $53,000 recorded in Q2 2010.
- Lexicon Pharmaceuticals' 5-year Non Operating Investment Income high stood at $517,000 for Q1 2009, and its period low was -$3.1 million during Q4 2009.
- Over the past 3 years, Lexicon Pharmaceuticals' median Non Operating Investment Income value was $70,500 (recorded in 2010), while the average stood at -$370,000.
- Data for Lexicon Pharmaceuticals' Non Operating Investment Income shows a maximum YoY crashed of 82.98% (in 2010) over the last 5 years.
- Over the past 3 years, Lexicon Pharmaceuticals' Non Operating Investment Income (Quarterly) stood at -$3.1 million in 2009, then tumbled by 82.98% to $53,000 in 2010, then plummeted by 60.23% to $35,000 in 2011.
- Its Non Operating Investment Income stands at $35,000 for Q1 2011, versus $53,000 for Q2 2010 and $88,000 for Q1 2010.